Premium
Anesthesia for noncardiac procedures for children with a Berlin Heart EXCOR ® Pediatric Ventricular Assist Device: a case series
Author(s) -
CAVE DOMINIC A.,
FRY KATHRYN M.,
BUCHHOLZ HOLGER
Publication year - 2010
Publication title -
pediatric anesthesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.704
H-Index - 82
eISSN - 1460-9592
pISSN - 1155-5645
DOI - 10.1111/j.1460-9592.2010.03314.x
Subject(s) - medicine , perioperative , anesthesia , population , odds ratio , anesthetic , ventricular assist device , heart failure , environmental health
Summary Objectives: To report our experience of providing anesthesia for noncardiac procedures in children with in situ Berlin Heart EXCOR Pediatric ® ventricular assist devices and to suggest principles of anesthetic management. Background: With the initiation of the first North American training and support center for Berlin Heart at our institution in 2006, we have been asked to provide anesthesia for noncardiac procedures to these children. No current anesthetic approach to these children has been reported. Methods/Materials: Anesthetic records for all noncardiac procedures for children with Berlin Heart between August 2006 and February 2009 in a tertiary care pediatric hospital were retrospectively reviewed. Charts were reviewed for demographic and clinical data, perioperative management, and occurrence of hypotension. Results: Twenty‐nine procedures were performed on 11 patients. Hypotension was a common occurrence with all anesthetic induction and maintenance agents even at low doses. Ketamine induction, however, was less likely to produce hypotension, odds ratio for hypotension 0.1333 (95% confidence range 0.021–0.856). Hypotension was responsive to fluid bolus (60%) and alpha‐receptor agonists (100%). Preoperative stability and presence of biventricular ventricular assist device (BiVAD) did not predict intraoperative hemodynamic course. Conclusions: Unlike patients with other ventricular assist devices, these children do not tolerate reductions in systemic vascular resistance (SVR) because of the relatively fixed cardiac output of this device. Agents that reduce SVR should be avoided where possible. Preoperative stability is not predictive. Fluids and alpha‐agonists should be first‐line response to hypotension in this population. Further study of this unusual population is warranted to further delineate best anesthetic practice.